| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/07/2008 | CA2660052A1 Compositions and methods for the modulation of jnk proteins |
| 02/07/2008 | CA2659835A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 02/07/2008 | CA2658799A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | CA2658797A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 02/07/2008 | CA2658282A1 1h-indol-6-yl-piperazin-1-yl-methanone-derivatives for use as h3 receptor modulators |
| 02/07/2008 | CA2657394A1 Preparation containing fibrate agent and process for producing the same |
| 02/07/2008 | CA2649044A1 Benzylphenyl glucopyranoside derivative |
| 02/06/2008 | EP1884513A1 Pyrazole compound and therapeutic agent for diabetes comprising the same |
| 02/06/2008 | EP1884247A2 Gastrin compositions and formulations, and methods of use and preparation |
| 02/06/2008 | EP1884243A1 Use of an antipsychotic drug for the treatment of ALS-associated cachexia |
| 02/06/2008 | EP1884238A1 Agent having antiobesity activity and method of inhibiting obesity |
| 02/06/2008 | EP1883417A2 Peptides, derivatives and analogs thereof, and methods of using same |
| 02/06/2008 | EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | CN101119993A Aminophenyl derivatives as selective androgen receptor modulators |
| 02/06/2008 | CN101119991A Salt of proline derivative, solvate thereof, and production method thereof |
| 02/06/2008 | CN101119978A HSP90-inhibiting triazole derivatives |
| 02/06/2008 | CN101119974A Amide derivatives as PPAR activators |
| 02/06/2008 | CN101119749A Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 02/06/2008 | CN101119748A Pharmaceutical composition for treatment of diabetes |
| 02/06/2008 | CN101119736A Amines, combination of amines and vanadium and amine vanadium salts for the treatment or prevention of dyslipidemia |
| 02/06/2008 | CN101119727A Use of cannabinoid receptor antagonists for the preparation of drugs in the treatment and prevention of type-2 diabetes |
| 02/06/2008 | CN101119726A Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
| 02/06/2008 | CN101117630A Preparation method of nattokinase powder and natto Brazil mushroom capsule |
| 02/06/2008 | CN101117349A A macrocyclic oxidation substituted pentacyclic triterpanoids derivative and preparation method and use thereof |
| 02/06/2008 | CN101117348A A and C macrocyclic oxidation substituted pentacyclic triterpanoids and preparation method and use thereof |
| 02/06/2008 | CN101117316A Oral liquid for preventing and remitting diabetes |
| 02/06/2008 | CN101116748A Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN101116686A Medicine for treating fatness and its complication |
| 02/06/2008 | CN101116675A Antihyperglycemic antisenescence medicinal composition and method for preparing the same |
| 02/06/2008 | CN101116672A Life equilibrium liquid |
| 02/06/2008 | CN101116671A Spacing mutagenicity high-yield highly-effective strain and use thereof |
| 02/06/2008 | CN101116512A Enteral feeding solutions contain an alkyl paraben to inhibit growth of micro-organisms in the enteral tube |
| 02/06/2008 | CN101116504A Health products for reducing blood fat and method for preparing the same |
| 02/06/2008 | CN101116503A Health products for reducing blood sugar and method for preparing the same |
| 02/06/2008 | CN101116502A Health products for reducing blood sugar and method for preparing the same |
| 02/06/2008 | CN101116487A Instant nutritive gruel having a function of stabilizing body blood sugar after meal and method for preparing the same |
| 02/06/2008 | CN101116466A Health-care tea for fat-reducing liver-fortifying and its preparing process thereof |
| 02/06/2008 | CN100366628C Effective parts of fructus sophorae flavone production and use thereof |
| 02/06/2008 | CN100366616C Novel bicyclic inhibitors of hormone sensitive lipase |
| 02/06/2008 | CN100366614C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/06/2008 | CN100366588C Rhizoma Anemarrhenae total phenol extract, its preparation method and application |
| 02/06/2008 | CN100366268C Plant essence with equalized fat acids |
| 02/06/2008 | CN100366254C Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 02/06/2008 | CN100366252C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion |
| 02/06/2008 | CN100366243C Process for preparation of dispersions |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326803 Skin disorders; antiinflammatory agents; antiproliferative agents; controlling metabolism; obesity; antilipemic agents; antihistamines |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326708 Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326701 Lactam compounds and pharmaceutical use thereof |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | US7326678 Obesity-related disease or disorder, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
| 02/05/2008 | US7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline |
| 02/05/2008 | CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 02/05/2008 | CA2315703C Tripeptidyl peptidase inhibitors |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 01/31/2008 | WO2008014299A2 Use of an alpha2-agonist composition for the treatment of hyperlipidemia |
| 01/31/2008 | WO2008013955A2 Sustained release formulations for pulmonary delivery |
| 01/31/2008 | WO2008013660A2 Inhibitors of advanced glycation end products |
| 01/31/2008 | WO2008013455A1 Means and methods for preventing elevated blood glucose levels in humans with animal antibodies produced in milk |
| 01/31/2008 | WO2008013324A1 Use of diabetes-related, liver-derived secreted protein in diagnosis or treatment of type-2 diabetes or vascular disorder |
| 01/31/2008 | WO2008013321A1 Novel sglt inhibitors |
| 01/31/2008 | WO2008013280A1 Substituted spiroketal derivative and use thereof as drug for treating diabetes |
| 01/31/2008 | WO2008013277A1 Fused ring spiroketal derivative and use thereof as drug for treating diabetes |
| 01/31/2008 | WO2008013067A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| 01/31/2008 | WO2008012952A1 Composition for stimulation of metabolism |
| 01/31/2008 | WO2008012932A1 Insulin resistance reducer |
| 01/31/2008 | WO2008012418A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/31/2008 | WO2008011713A1 Methods of diagnosis and treatment for metabolic disorders |
| 01/31/2008 | WO2007139833A3 Imidazoazephinone compounds |
| 01/31/2008 | WO2007124045A3 Piperidine and piperazine compounds for use in the treatment of obesity, eating disorders and sexual dysfunction by potentiation of mc4 receptor activity |
| 01/31/2008 | WO2007002559A8 Pyrazole based lxr modulators |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027139 Use of Alpha-Ketoglutarate and Related Compounds |
| 01/31/2008 | US20080027138 Novel NIDDM Regimen |
| 01/31/2008 | US20080027134 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use |
| 01/31/2008 | US20080027131 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| 01/31/2008 | US20080027125 Fluvastatin sodium novel forms and preparation thereof |
| 01/31/2008 | US20080027122 antidiabetic agents; 4-chloro-3-(4-ethylphenylmethyl)-1-( beta -D-glucopyranosyl)indole; hypoglycemic agent, wound healing agent, antilipemic agents, hypotensive agent; chemical synthesis with a chemical intermediates |
| 01/31/2008 | US20080027121 Novel pyrone-indole derivatives and process for their preparation |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027098 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation |
| 01/31/2008 | US20080027096 Novel Pharmaceutical Compositions |
| 01/31/2008 | US20080027093 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/31/2008 | US20080027090 N-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-yl-3,3-dimethylbutanamide; for treating cardiovascular disorders, nervous system disorders e.g epilepsy, episodic ataxia type 1, paroxysmal dyskinesia, neurodegenerative spincerebrallar ataxia, Parkinson's disease |
| 01/31/2008 | US20080027088 Imidazole-Based Hmg-Coa Reductase Inhibitors |
| 01/31/2008 | US20080027087 CB1 antagonists and inverse agonists |
| 01/31/2008 | US20080027084 antiinflammatory agent, anticarcinogenic agent; for treating inflammatory diseases, allergic, autoimmune, metabolic, cancer, cardiovascular diseases |
| 01/31/2008 | US20080027083 Modulators of chemokine receptor activity crystalline forms and process |
| 01/31/2008 | US20080027080 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | US20080027078 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 01/31/2008 | US20080027077 Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/31/2008 | US20080027072 Potentiation of MC4 receptor activity |
| 01/31/2008 | US20080027070 2-amino--5-substituted pyrimidine inhibitors |
| 01/31/2008 | US20080027065 G protein coupled receptor inhibitors (Gpr38) such as 6-[(4-fluorophenyl)oxy]-N-methyl-N-(4-{[(3S)-3-methyl-1-piperazinyl]methyl}phenyl)-3-pyridinecarboxamide for treatment of gastric stasis in an enterally fed patient |